On May 19-20, 2018 Tbilisi State Medical University and Georgian Society of Medical Genetics and Epigenetics organized the International Conference – “Human Genome and Health” from May 19-20, 2018 in Courtyard by Marriott, Tbilisi, Georgia. The conference was funded by the Shota Rustaveli National Science Foundation of Georgia.

The aim of the Conference was to provide the targeted audience with the latest scientific advancements on the respective field and to share the modern technologies and experience in the fields of medical genetics.

It is noteworthy that the leading field experts from Georgia and the whole world participated in the Conference including the KU Leuven University (Belgium); Cardiff University (the UK) Mayo Clinic, (USA); University of Scripps (USA); Lund University (Sweden); Stanford University (USA); Radblaud University (the Netherlands); Yerevan University (Armenia) etc.

The conference consisted of five plenary sessions, focusing on important topics such as:  Problems related to the use of modern medical genetic tests in the healthcare system;  Screening of the genetics of population, namely the receptive diseases of the population, as well as the method of assessing the medical genetic tests that are often used in the field of health care to evaluate positive and negative genetic tests; Ethical problems in the medical genetics, in particular, the problems of management (incidental / secondary findings) of unexpectedly resulting sequencing;  The role of genome diagnosis to determine rare chromosomal anomalies; use of Artificial intelligence in the evaluation of rare genetic diseases; Current research in Georgia concerning the genetics of the tumor and epigenetics;  hereditary thrombophilia and personalized medicine in Georgia; The role of genetic factors of spontaneous abortion in Georgia; The role of further generation sequencing applications in C hepatitis elimination program in Georgia etc.

The workshop was another part of the conference: (Face2Gene) use of artificial intelligence in clinical practice in diagnosing rare genetic diseases. At the conference, Face2Gene program was introduced with the audience, which enables to provide information about patients’ photographs and clinical information in the portal and provides an opportunity to diagnose patients with dysmorphic signs using phenotypic information.

At the end of the conference, the awarding ceremony of the winner students participating in the essay competition related to DNA day was held.